Grazyna Faure

Dr. Grazyna Faure

Institut Pasteur
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Journal of Molecular Biology
Verified
Journal Article
Closed access
GFGrazyna Faure
Grazyna Faure
HXHaijin Xu
Haijin Xu
FSFrederick A. Saul
Frederick A. Saul

1 March 2010 in Journal of Structural Biology
Verified
Journal Article
Closed access
FSFrederick A. Saul
Frederick A. Saul
PPPetra Prijatelj-Žnidaršič
Petra Prijatelj-Žnidaršič
BNBrigitte Vulliez-Le Normand
Brigitte Vulliez-Le Normand
BVBenoit Villette
Benoit Villette
BRBertrand Raynal
Bertrand Raynal
GFGrazyna Faure
Grazyna Faure


1 July 2016 in Journal of Molecular Biology
Verified
Journal Article
Closed access
GFGrazyna Faure
Grazyna Faure
NBNaziha Bakouh
Naziha Bakouh
SLStéphane Lourdel
Stéphane Lourdel
NONorbert Odolczyk
Norbert Odolczyk
APAiswarya Premchandar
Aiswarya Premchandar
AEAleksander Edelman
Aleksander Edelman

13 November 2020 in Molecules
Verified
Journal Article
Open access
PDF file
DNDorota Nemecz
Dorota Nemecz
MOMaciej Ostrowski
Maciej Ostrowski
MRMarc Ravatin
Marc Ravatin
FSFrederick Saul
Frederick Saul
GFGrazyna Faure
Grazyna Faure
Crotoxin, from the venom of the South American rattlesnake Crotalus durissus terrificus, is a potent heterodimeric presynaptic β-neurotoxin that exists in individual snake venom as a mixture of isoforms of a basic phospholipase A2 (PLA2) subunit (CBa2, CBb, CBc, and CBd) and acidic subunit (CA1–4). Specific natural mutations in CB isoforms are implicated in functional differences between crotoxin isoforms. The three-dimensional structure of two individual CB isoforms (CBa2, CBc), and one isoform in a crotoxin (CA2CBb) complex, have been previously reported. This study concerns CBd, which by interaction with various protein targets exhibits many physiological or pharmacological functions. It binds with high affinity to presynaptic receptors showing neurotoxicity, but also interacts with human coagulation factor Xa (hFXa), exhibiting anticoagulant effect, and acts as a positive allosteric modulator and corrector of mutated chloride channel, cystic fibrosis transmembrane conductance regulator (CFTR), implicated in cystic fibrosis. Thus, CBd represents a novel family of agents that have potential in identifying new drug leads related to anticoagulant and anti-cystic fibrosis function. We determined here the X-ray structure of CBd and compare it with the three other natural isoforms of CB. The structural role of specific amino acid variations between CB isoforms are analyzed and the structural framework of CB for interaction with protein targets is described.

1 June 2016 in Toxicon
Verified
Journal Article
Closed access
MOMaciej Ostrowski
Maciej Ostrowski
DPDorota Porowinska
Dorota Porowinska
TPTomasz Prochnicki
Tomasz Prochnicki
MPMarie Prevost
Marie Prevost
BRBertrand Raynal
Bertrand Raynal
GFGrazyna Faure
Grazyna Faure